SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Patrick Serafino who wrote (1598)3/31/1998 1:04:00 PM
From: Frank Buck  Read Replies (2) of 1894
 
Patrick,

Some very interesting comments made during the AccuMed conference call. The Virginia Lab issue was addressed. It is an old issue, and while AccuMed admits to dropping the ball...it was dropped at a point some time ago.

An impending strategic alliance with another publicly traded concern is pending announcement. From the conference call, I think we can rule out NeoPath and NeuroMedical.

11-12 buyers are currently looking at AccuMed's non-core microbiology line. Serious bids should be submitted within a six-week period.

Patrick, I wouldn't count out the possibility that the share price will not get back to your initial entry period just yet.

The reception by the 150 people in attendance at the recent Chicago seminar was encouraging for future sales of the AcCell/TracCell system. The benefit gains in productivity are documented and the strategic alliance with this new publicly traded concern should strengthen those gains. I for one am hoping that it is with a certain Liquid Based Player.

Cisco...do we know any of these guys?

Any guesses who this strategic partner can be????

Frank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext